{
  "docId": "019de073-4386-7700-b700-92166fcbcd7c",
  "docSlug": "fd316ea801ff13186537922fd8d6b6b2",
  "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 28,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_disclosure",
  "function": "other",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "Standard pharmaceutical regulatory disclosure slide.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/3",
  "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c",
  "deckJsonHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c.json",
  "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.904,
        "x": 0.048,
        "y": 0.745
      },
      "kind": "disclaimer",
      "text": "The black equilateral triangle ▼ denotes that additional monitoring is required to capture any adverse reactions. This will allow quick identification of new safety information.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0de71171-ce2b-42c6-9d14-167498c81793",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.904,
        "x": 0.048,
        "y": 0.325
      },
      "kind": "list",
      "text": "Events of anaphylaxis have been reported. Very rare cases of myocarditis and pericarditis have been observed. Anxiety-related reactions may occur. Efficacy not assessed in immunocompromised. Protection starts 7 days after second dose. Common side effects listed.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d553d69-c17c-40c2-9d6a-eff42edce20f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.215,
        "x": 0.048,
        "y": 0.302
      },
      "kind": "paragraph",
      "text": "IMPORTANT SAFETY INFORMATION:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbe03146-a014-40d7-ad95-e93c034b5cb8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.904,
        "x": 0.048,
        "y": 0.195
      },
      "kind": "paragraph",
      "text": "COMIRNATY® ▼ (the Pfizer-BioNTech COVID-19 vaccine) has been granted conditional marketing authorization (CMA) by the European Commission to prevent coronavirus disease 2019 (COVID-19) in people from 5 yrs of age.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dce902b7-aa3b-4475-8488-bbc7188ce1d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.235,
        "x": 0.048,
        "y": 0.105
      },
      "kind": "title",
      "text": "Safety Information",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca0b0cc7-9041-472e-b592-09d857c3a196",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "37ddc45b-bb80-48ee-b125-7fade60bed99",
      "evidence": "list/bullet: Events of anaphylaxis have been reported. Very rare cases of myocarditis and pericarditis have been observed.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}